According to Paata Imnadze, the Deputy Director of the National Center for Disease Control, the study process will begin in September.

“Summer and early fall, most likely, be relatively calm. I don’t think that there will be any problems for the resumption of studies. Unfortunately, the prognosis is such that we should not hope for the disappearance of coronavirus. And if we don’t have an effective antiviral drug for next winter, the virus can return again in the winter. Therefore, we must be ready for a bad scenario”, - said Paata Imnadze.